Accelerating antibody & nanobody design for research use cases with Generative AI
Role of Antibodies in research Antibodies are foundational tools in research and diagnostics in addition to being the largest biological modality in […]
Target elucidation: Key first steps for structure based in silico drug design
BioPharma wins come after long and hard fought battles. Every phase of a drug discovery battle poses its own challenges. Deep Science and Deep Tech innovations are continuously expanding the options available for addressing these challenges.
Industry-Academia collaborations to design next generation anti-malaria drugs
Partnership between academic research institutions and the biopharma industry has been essential for making breakthrough discoveries in disease research and translating those discoveries into therapies available in the clinic.
Rare Disease Day, 2024
Rare diseases affect a staggering 300 million people worldwide. Often genetic in origin, rare diseases demand our attention and support for research. On Rare Disease Day, we highlight the challenges faced by these individuals and the urgent need for solutions.
AI Everywhere
A lot changed in 2023. The widespread use of AI through ChatGPT changed perceptions of the use and relevance of AI in creative tasks.Beyond its ability to seemingly understand questions and generate responses in natural language, we at Aganitha see an opportunity to make AI understand and speak the language of life - DNA, RNA, protein sequences, molecules, genes, targets, drugs, and so on.